Literature DB >> 23135882

Anti-M3 muscarinic acetylcholine receptor antibodies in patients with Sjögren's syndrome.

Takayuki Sumida1, Hiroto Tsuboi, Mana Iizuka, Hiromitsu Asashima, Isao Matsumoto.   

Abstract

Sjögren's syndrome (SS) is an autoimmune disease that affects exocrine glands including salivary and lacrimal glands. Recently, autoantibodies against muscarinic acetylcholine receptor M3 (M3R) have been detected in serum from 9 to 100 % of patients with SS in addition to anti-SS-A and anti-SS-B antibodies. These observations suggest the possibility that anti-M3R antibodies could serve as a new diagnostic test in patients with SS. Some anti-M3R antibodies are directly responsible for salivary underproduction in patients with SS. Thus, strategies designed to eliminate such pathogenic antibodies could help cure SS sufferers. In this review, we summarize the current state of knowledge of anti-M3R autoantibodies in patients with SS and the correlation between B cell epitopes and the function of anti-M3R antibodies.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23135882     DOI: 10.1007/s10165-012-0788-5

Source DB:  PubMed          Journal:  Mod Rheumatol        ISSN: 1439-7595            Impact factor:   3.023


  13 in total

1.  Prevalence and pathogenicity of autoantibodies in patients with idiopathic CD4 lymphopenia.

Authors:  Ainhoa Perez-Diez; Chun-Shu Wong; Xiangdong Liu; Harry Mystakelis; Jian Song; Yong Lu; Virginia Sheikh; Jeffrey S Bourgeois; Andrea Lisco; Elizabeth Laidlaw; Cornelia Cudrici; Chengsong Zhu; Quan-Zhen Li; Alexandra F Freeman; Peter R Williamson; Megan Anderson; Gregg Roby; John S Tsang; Richard Siegel; Irini Sereti
Journal:  J Clin Invest       Date:  2020-10-01       Impact factor: 14.808

Review 2.  Sjögren syndrome.

Authors:  Clio P Mavragani; Haralampos M Moutsopoulos
Journal:  CMAJ       Date:  2014-02-24       Impact factor: 8.262

Review 3.  Update on Pathogenesis of Sjogren's Syndrome.

Authors:  Pulukool Sandhya; Biji Theyilamannil Kurien; Debashish Danda; Robert Hal Scofield
Journal:  Curr Rheumatol Rev       Date:  2017

4.  Muscarinic acetylcholine receptor-mediated tight junction opening is involved in epiphora in late phase of submandibular gland transplantation.

Authors:  Ning-Yan Yang; Chong Ding; Jing Li; Yan Zhang; Ruo-Lan Xiang; Li-Ling Wu; Guang-Yan Yu; Xin Cong
Journal:  J Mol Histol       Date:  2017-01-11       Impact factor: 2.611

5.  Proteasome inhibition suppresses Th17 cell generation and ameliorates autoimmune development in experimental Sjögren's syndrome.

Authors:  Fan Xiao; Xiang Lin; Jie Tian; Xiaohui Wang; Qian Chen; Ke Rui; Jie Ma; Shengjun Wang; Qingwen Wang; Xiaoqi Wang; Dongzhou Liu; Lingyun Sun; Liwei Lu
Journal:  Cell Mol Immunol       Date:  2017-07-10       Impact factor: 11.530

6.  Pelvic floor dysfunction in female Sjögren's syndrome: an 8-year audit.

Authors:  Aaron K Budden; Nèvine I D Te West; Allan D Sturgess; Kate H Moore
Journal:  Int Urogynecol J       Date:  2016-03-10       Impact factor: 2.894

7.  Residual salivary secretion ability may be a useful marker for differential diagnosis in autoimmune diseases.

Authors:  Etsuko Maeshima; Hiroya Koshiba; Kanako Furukawa; Shinichiro Maeshima; Wataru Sakamoto
Journal:  Dis Markers       Date:  2014-11-20       Impact factor: 3.434

Review 8.  Interactions between developing nerves and salivary glands.

Authors:  João N Ferreira; Matthew P Hoffman
Journal:  Organogenesis       Date:  2013-06-06       Impact factor: 2.500

9.  Common molecular mechanism of the hepatic lesion and the cardiac parasympathetic regulation in chronic hepatitis C infection: a critical role for the muscarinic receptor type 3.

Authors:  Sanja Glišić; David P Cavanaugh; Krishnan K Chittur; Milan Sencanski; Vladimir Perovic; Tijana Bojić
Journal:  BMC Bioinformatics       Date:  2016-03-22       Impact factor: 3.169

10.  Sexual dimorphism in an animal model of Sjögren's syndrome: a potential role for Th17 cells.

Authors:  Alexandria Voigt; Lida Esfandiary; Cuong Q Nguyen
Journal:  Biol Open       Date:  2015-10-09       Impact factor: 2.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.